Which of the following best describes the principle of lead time bias in screening programs?

Explanation

## Lead Time Bias in Screening **Key Point:** Lead time bias occurs when screening appears to improve survival time simply because disease is detected earlier, not because the disease course is altered or mortality is reduced. ### Definition & Mechanism Lead time is the interval between detection of disease by screening and when it would have been detected by clinical symptoms. Screening advances the time of diagnosis without changing the actual time of death, creating an illusion of improved survival. ### Example If a cancer is detected by screening at age 50 and patient dies at age 60, versus clinical detection at age 55 with death at age 60: - Screening: apparent survival = 10 years - Clinical detection: apparent survival = 5 years - **Actual survival time unchanged = 5 years** (death still occurs at age 60) ### Clinical Significance - Survival time increases but mortality rate remains unchanged - Screening may appear beneficial when it is not - Addressed by using **mortality rates** rather than survival time as outcome measure - **Length-time bias** is a related phenomenon where screening preferentially detects slower-growing, less aggressive cancers **High-Yield:** Lead time bias is why mortality reduction (not survival improvement) is the gold standard for evaluating screening effectiveness. [cite:Park 26e Ch 10] **Mnemonic:** **LTB = Lead Time = Earlier detection, not Better outcome**